Latest PSNC News

Visit PSNC website
  • The Department of Health and Social Care (DHSC) has published a new version of the list of community pharmacies eligible for the Pharmacy Access Scheme (PhAS). A review process for the 2022 Scheme approved 43 cases out of 63 applications submitted, bringing the total number of eligible pharmacies to 1,445. Earlier this year, NHS England […]
  • Following the Government’s announcement about the end of national shielding in England, NHS Digital is seeking to undertake a managed closure of the Shielded Patient List. Consequently, the Summary Care Record (SCR) application has been updated: The “COVID-19 Risk Indicators” section has been removed from the “Key Demographic Information” page; and the associated alert has now been […]
  • NHS England and NHS Improvement (NHSE&I), in association with the Royal Pharmaceutical Society (RPS) and the Association of Pharmacy Technicians UK (APTUK) has published its first Inclusive Pharmacy Practice (IPP) Bulletin. As a member of the IPP Improving Practice and Engagement Group, PSNC has contributed to this issue of the Bulletin, which focuses on how […]
  • Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 9 new products will be classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 July 2022. This takes the total number of products granted DND status over the past 2 […]
  • Community pharmacy contractors are not required to submit their completed New Medicine Service (NMS) summary data to the NHS Business Services Authority for April to June 2022 as this requirement has been postponed again for this quarter. In December, PSNC advised that this requirement, which was suspended during the pandemic, would be re-instated from Quarter […]
  • Department of Health and Social Care (DHSC) has issued a medicine supply notification for Eletriptan (Relpax®) 20mg tablets. MSN/2022/058 Tier 2 – medium impact Date of issue 30th June 2022 Eletriptan (Relpax®) 20mg tablets are out of stock until w/c 1st Aug 2022. Alternative triptans remain available and can support the increased demand. A copy […]